Bolt Biotherapeutics, Inc. Logo

Bolt Biotherapeutics, Inc.

Clinical-stage biotech developing immuno-oncology therapies using the innate immune system.

BOLT | US

Overview

Corporate Details

ISIN(s):
US0977021049
LEI:
Country:
United States of America
Address:
900 CHESAPEAKE DRIVE, 94063 REDWOOD CITY

Description

Bolt Biotherapeutics is a clinical-stage biotechnology company developing immuno-oncology therapies to treat cancer. The company's approach leverages the innate immune system, particularly myeloid cells, to create a therapeutic anti-tumor response. Its proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) platform combines tumor-targeting antibodies with immune-stimulating agents. This technology is designed to repolarize tumor-supportive immune cells, such as macrophages, into tumor-destructive ones, while also activating the adaptive immune system. The company's pipeline includes multiple candidates generated from the ISAC platform and other novel approaches. A key candidate, BDC-3042, is a first-in-class Dectin-2 agonist antibody being evaluated in clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Bolt Biotherapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bolt Biotherapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bolt Biotherapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.